MedTrace Logo

The Major Bleeding Risk Following Hepatectomy

NCT04748081 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5265

Last updated 2021-02-10

No results posted yet for this study

Summary

This study examined long-term incidence rates of major bleeding associated with hepatectomy. The investigators used data from Taiwan's National Health Insurance Research Database. Patients who underwent hepatectomy between 2000 and 2012 were identified by International Classification of Diseases, Ninth Revision, Clinical Modification codes. Variables including gender, age, comorbidities, and prescribed medications were matched between cases and controls. A total of 1,053 patients with hepatectomy and 4,212 matched non-hepatectomy subjects were included in this study.

Conditions

  • Gastrointestinal Hemorrhage
  • Postoperative Hemorrhage
  • Surgery--Complications

Interventions

PROCEDURE

hepatectomy

hepatectomy (ICD-9-CM procedure code: 50.2, 50.22, 50.3 and 50.4)

Sponsors & Collaborators

  • An-Nan Hospital, China Medical University

    collaborator OTHER

  • Ministry of Health and Welfare, Taiwan

    collaborator OTHER_GOV

  • China Medical University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-01-01
Primary Completion
2012-12-31
Completion
2018-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04748081 on ClinicalTrials.gov